Cyanotech Corporation operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cyanotech with three other pharmaceutical manufacturers in North America: C21 Investments Inc of CANADA (2020 sales of 49.93 million Canadian Dollars [US$39.13 million] ), Shineco Inc ($23.68 million of which 56% was Herbal products), and Supreme Cannabis Company Inc which is based in CANADA (39.75 million Canadian Dollars [US$31.15 million] ).

Sales Analysis. During the year ended March of 2020, sales at Cyanotech were $31.90 million. This is an increase of 5.6% versus 2019, when the company's sales were $30.20 million. Despite this increase, sales are still below the level achieved in 2018, when Cyanotech reported sales of $34.12 million. The sales level in 2020 was fairly close to the level five years ago: in 2015, Cyanotech had sales of $33.81 million.